BD Gets CE Mark for C. difficile Molecular Test | GenomeWeb
NEW YORK (GenomeWeb News) – Becton Dickinson said today that European Union regulatory authorities have granted the CE Mark for its BD GeneOhm Cdiff molecular diagnostic test for patients with Clostridium difficile infection.
The assay detects the toxin B gene, which is found in toxigenic C. difficile strains, directly from stool specimens. BD said that it is the only C. difficile test on the market that offers high sensitivity and a rapid turnaround time of less than two hours.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.